Prothena

$23.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.46 (+6.66%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Prothena and other stocks, options, and ETFs commission-free!

About PRTA

Prothena Corporation plc Ordinary Shares, also called Prothena, is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases.

CEO

Gene G. Kinney

Employees

Headquarters

Dun Laoghaire, Dublin

Founded

1969

Market Cap

1.10B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

397.09K

High Today

$24.20

Low Today

$21.73

Open Price

$22.28

Volume

314.85K

52 Week High

$28.66

52 Week Low

$9.25

Analyst Ratings

86%

of 7 ratings

Buy

86%

Hold

Sell

14%

PRTA Earnings

-$0.77

-$0.51

-$0.26

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, Pre-Market